Fibroblast growth factor receptor 3 activation plays a causative role in urothelial cancer pathogenesis in cooperation withPtenloss in mice
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Fibroblast growth factor receptor 3 activation plays a causative role in urothelial cancer pathogenesis in cooperation withPtenloss in mice
Authors
Keywords
-
Journal
JOURNAL OF PATHOLOGY
Volume 233, Issue 2, Pages 148-158
Publisher
Wiley
Online
2014-02-12
DOI
10.1002/path.4334
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- PI3K/AKT pathway activation in bladder carcinogenesis
- (2013) Julien Calderaro et al. INTERNATIONAL JOURNAL OF CANCER
- PIK3CAgene alterations in bladder cancer are frequent and associate with reduced recurrence in non-muscle invasive tumors
- (2013) Marta Dueñas et al. MOLECULAR CARCINOGENESIS
- Exploring mechanisms of FGF signalling through the lens of structural biology
- (2013) Regina Goetz et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- A comprehensive immunohistochemical and molecular approach to the PI3K/AKT/mTOR (phosphoinositide 3-kinase/v-akt murine thymoma viral oncogene/mammalian target of rapamycin) pathway in bladder urothelial carcinoma
- (2012) Penelope Korkolopoulou et al. BJU INTERNATIONAL
- AZD4547: An Orally Bioavailable, Potent, and Selective Inhibitor of the Fibroblast Growth Factor Receptor Tyrosine Kinase Family
- (2012) P. R. Gavine et al. CANCER RESEARCH
- Molecular Pathways: Fibroblast Growth Factor Signaling: A New Therapeutic Opportunity in Cancer
- (2012) A. N. Brooks et al. CLINICAL CANCER RESEARCH
- A Molecular Taxonomy for Urothelial Carcinoma
- (2012) G. Sjodahl et al. CLINICAL CANCER RESEARCH
- FGFR3 targeting strategies for achondroplasia
- (2012) Melanie B. Laederich et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- Mutations in FGFR3 and PIK3CA, singly or combined with RAS and AKT1, are associated with AKT but not with MAPK pathway activation in urothelial bladder cancer
- (2012) Nuria Juanpere et al. HUMAN PATHOLOGY
- PIK3CA mutation spectrum in urothelial carcinoma reflects cell context-dependent signaling and phenotypic outputs
- (2012) R L Ross et al. ONCOGENE
- K-Ras and -catenin mutations cooperate with Fgfr3 mutations in mice to promote tumorigenesis in the skin and lung, but not in the bladder
- (2011) I. Ahmad et al. Disease Models & Mechanisms
- Discovery of 3-(2,6-Dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimidin-4-yl}-1-methyl-urea (NVP-BGJ398), A Potent and Selective Inhibitor of the Fibroblast Growth Factor Receptor Family of Receptor Tyrosine Kinase
- (2011) Vito Guagnano et al. JOURNAL OF MEDICINAL CHEMISTRY
- Hedgehog/Wnt feedback supports regenerative proliferation of epithelial stem cells in bladder
- (2011) Kunyoo Shin et al. NATURE
- Phosphatidylinositol 3'-kinase, mTOR, and Glycogen synthase kinase-3β mediated regulation of p21 in human urothelial carcinoma cells
- (2011) Nicole L Yohn et al. BMC Urology
- Small molecule FGF receptor inhibitors block FGFR-dependent urothelial carcinoma growth in vitro and in vivo
- (2010) F R Lamont et al. BRITISH JOURNAL OF CANCER
- Fibroblast growth factor signaling in development of the cerebral cortex
- (2010) Tomoko Iwata et al. DEVELOPMENT GROWTH & DIFFERENTIATION
- β-Catenin activation synergizes with PTEN loss to cause bladder cancer formation
- (2010) I Ahmad et al. ONCOGENE
- FGFR3, HRAS, KRAS, NRAS and PIK3CA Mutations in Bladder Cancer and Their Potential as Biomarkers for Surveillance and Therapy
- (2010) Lucie C. Kompier et al. PLoS One
- Molecular pathways of urothelial development and bladder tumorigenesis
- (2010) Mireia Castillo-Martin et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Fibroblast Growth Factor Receptor 1 Promotes Proliferation and Survival via Activation of the Mitogen-Activated Protein Kinase Pathway in Bladder Cancer
- (2009) D. C. Tomlinson et al. CANCER RESEARCH
- A Modified Sleeping Beauty Transposon System That Can Be Used to Model a Wide Variety of Human Cancers in Mice
- (2009) A. J. Dupuy et al. CANCER RESEARCH
- Spectrum of Phosphatidylinositol 3-Kinase Pathway Gene Alterations in Bladder Cancer
- (2009) F. M. Platt et al. CLINICAL CANCER RESEARCH
- The Updated EAU Guidelines on Muscle-Invasive and Metastatic Bladder Cancer
- (2009) Arnulf Stenzl et al. EUROPEAN UROLOGY
- Inactivation of p53 and Pten promotes invasive bladder cancer
- (2009) A. M. Puzio-Kuter et al. GENES & DEVELOPMENT
- Antibody-based targeting of FGFR3 in bladder carcinoma and t(4;14)-positive multiple myeloma in mice
- (2009) Jing Qing et al. JOURNAL OF CLINICAL INVESTIGATION
- AKT1 mutations in bladder cancer: identification of a novel oncogenic mutation that can co-operate with E17K
- (2009) J M Askham et al. ONCOGENE
- Molecular pathogenesis of bladder cancer
- (2008) Margaret A. Knowles International Journal of Clinical Oncology
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now